Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report Forecast 2017-2021

March 2017 | 100 pages | ID: G3119380FAEEN
S&P Consulting

Abstracts

The Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Non-alcoholic Fatty Liver Disease (NAFLD) Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Non-alcoholic Fatty Liver Disease (NAFLD) Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market: Regional Segment Analysis

North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:

Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market: Product Segment Analysis

Type 1
Type 2
Type 3


Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market: Application Segment Analysis

Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report Forecast 2017-2021

CHAPTER 1 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Segmentation by Type
  1.2.1 Global Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Segmentation by Application
  1.3.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug (2012-2021)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKET COMPETITION BY MANUFACTURERS

3.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Share by Manufacturers (2015 and 2016)
3.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competitive Situation and Trends
  3.5.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Concentration Rate
  3.5.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production by Region (2012-2017)
4.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Market Share by Region (2012-2017)
4.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption by Regions (2012-2017)
5.2 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Market Share by Type (2012-2017)
6.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2012-2017)
6.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price by Type (2012-2017)
6.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKET ANALYSIS BY APPLICATION

7.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption and Market Share by Application (2012-2017)
7.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MANUFACTURERS ANALYSIS

8.1 Conatus Pharmaceuticals
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Daewoong Pharmaceutical
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Galmed International
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 Kyorin Pharmaceutical
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Metabolic Solutions Development
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Novartis AG
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Phenex Pharmaceuticals
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Raptor Pharmaceuticals
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 TCM Biotech International
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

CHAPTER 9 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MANUFACTURING COST ANALYSIS

9.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKET FORECAST (2017-2021)

13.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue Forecast (2017-2021)
13.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption Forecast by Regions (2017-2021)
13.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Forecast by Type (2017-2021)
13.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast by Application (2017-2021)
13.5 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price Forecast (2017-2021)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Global Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) and Growth Rate (2012-2021)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million UDS) and Growth Rate (2012-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity of Key Manufacturers (2015 and 2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity of Key Manufacturers in 2015
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity of Key Manufacturers in 2016
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production of Key Manufacturers (2015 and 2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Share by Manufacturers
Figure 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Share by Manufacturers
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table 2016 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table Global Market Non-alcoholic Fatty Liver Disease (NAFLD) Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Non-alcoholic Fatty Liver Disease (NAFLD) Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share of Top 3 Manufacturers
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share of Top 5 Manufacturers
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity by Regions (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Market Share by Regions (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Market Share by Regions (2012-2017)
Figure 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Market Share by Regions
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production by Regions (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Market Share by Regions (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Market Share by Regions (2012-2017)
Figure 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Market Share by Regions
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue by Regions (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Market Share by Regions (2012-2017)
Table 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Market Share by Regions
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market by Regions (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Regions (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Regions
Table North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Import & Export (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Import & Export (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Import & Export (2012-2017)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Import & Export (2012-2017)
Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Import & Export (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production by Type (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Share by Type (2012-2017)
Figure Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2012-2017)
Figure 2015 Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue by Type (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2012-2017)
Figure 2015 Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price by Type (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Growth by Type (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption by Application (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Application (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Application in 2015
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Growth Rate by Application (2012-2017)
Table Conatus Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Daewoong Pharmaceutical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Galmed International Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Kyorin Pharmaceutical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Metabolic Solutions Development Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Novartis AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Phenex Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Raptor Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table TCM Biotech International Basic Information, Manufacturing Base, Production Area and Its Competitors
Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
Table Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
Table Major Buyers of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Distributors/Traders List
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Growth Rate Forecast (2017-2021)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Forecast by Regions (2017-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast by Regions (2017-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Forecast by Type (2017-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

Conatus Pharmaceuticals, Daewoong Pharmaceutical, Galmed International, Kyorin Pharmaceutical, Metabolic Solutions Development, Novartis AG, Phenex Pharmaceuticals, Raptor Pharmaceuticals, TCM Biotech International, Tobira Therapeutics, Verva Pharmaceuticals, Zafgen